HCRT and depressive disorder: Preclinical studies have shown that stress-induced activation of hypocretin/orexin receptors produces depression-like behaviors via an increase in p-CaMKIIα in mice and that siRNA-mediated inhibition of CaMKIIα counteracted the stress-induced depression-like behaviors [6].